Star Health & Allied Insurance Company Ltd
Star Health & Allied Insurance Company Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
What the Q4 FY26 call signalled
1 of 2 strong
The short version
Star Health aims for profitable, sustainable growth rather than just market share expansion. Star Health expects steady growth on an N basis with upwards of 39% growth for FY26. - Profitable growth remains a key focus, targeting profitable geographies and consumer cohorts rather than just market share expansion. - Fresh retail business growth driven by both value and volume, with retail policies expanding by 11% YoY in Q4 FY26. - Continued price increases planned, aligned with product performance and actuarial principles. - Loss ratio improvements expected to sustain due to repricing and better portfolio mix, supporting underwriting profitability. - Normalized profit after tax rose 45% YoY in FY26 to Rs.
From Star Health & Allied Insurance Company Ltd's Q4 FY26 earnings-call transcript · updated 24 Aug 2026.
Revenue & Sales Performance
- Star Health aims for profitable, sustainable growth rather than just market share expansion.
- Fresh retail growth is expected to remain strong with a focus on value and volume; fresh retail growth was 38% YoY in Q4 FY26.
- New-to-insurance mix remains high (~94%-95% on fresh premium), targeting new, profitable customer cohorts.
- Company projects NEP growth of upwards of 39% for FY26 and expects this to improve further with long-term policies accruing in NEP.
- Growth targets include maintaining a steady state industry growth alignment of 70-80% overall.
- Focus on profitable geographies and segments like SME with growth targets aligned to organizational objectives.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Star Health & Allied Insurance Company Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
2 more points management made on capital expenditure plans
Top-ranked in Insurance
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Star Health & Allied Insurance Company Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Star Health & Allied Insurance Company Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹4.6K Cr, net profit ₹111 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Star Health & Allied Insurance Company Ltd's management said in earlier quarters
- Q2 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
Others in Insurance this season
- New India Assurance Company Ltd (Q4 FY26)
Domestic gross direct premium grew by 10.9% in FY26, with a market share increase from 12.56% to 12.74%. Key concall takeaways from New India Assurance Company…
- Go Digit General Insurance Ltd (Q4 FY26)
For fiscal years '25 and '26, retail health business is under 6% of total health segment, indicating room for growth. Key concall takeaways from Go Digit…
- Medi Assist Healthcare Services Ltd (Q4 FY26)
Core group business organic growth currently tracking at 8%-10% (same-store growth). Key concall takeaways from Medi Assist Ser.'s Q4 FY26 earnings call — and…
- HDFC Life Insurance Company Ltd (Q4 FY26)
FY26 individual APE growth was 7% YoY, with a slowdown in Q4 due to GST and global uncertainties; proprietary channels grew 15-16%. Key concall takeaways from…
Frequently Asked Questions
What were Star Health & Allied Insurance Company Ltd Q4 FY26 results?
Star Health aims for profitable, sustainable growth rather than just market share expansion. Star Health expects steady growth on an N basis with upwards of 39% growth for FY26. - Profitable growth remains a key focus, targeting profitable geographies and consumer cohorts rather than just market share expansion. - Fresh retail business growth driven by both value and volume, with retail policies expanding by 11% YoY in Q4 FY26. - Continued price increases planned, aligned with product performance and actuarial principles. - Loss ratio improvements expected to sustain due to repricing and better portfolio mix, supporting underwriting profitability. - Normalized profit after tax rose 45% YoY in FY26 to Rs.
What is Star Health & Allied Insurance Company Ltd share price analysis?
Star Health & Allied Insurance Company Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 40.3 with a market cap of ₹34,052 Cr. Investors should review the full earnings analysis for detailed insights.
Is Star Health & Allied Insurance Company Ltd planning capital expenditure?
The transcript does not explicitly mention specific current or future capex or strategic capital investments.
Keep Star Health & Allied Insurance Company Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
